Table 2.
Demographics and imaging findings are shown for the whole group and the hypertension sub-groups. p-values reflect differences between the sub-groups based on logistic regression for continuous variables and Pearson’s chi-squared test for binary variables.
| All Patients (n=65) |
Patients without Hypertension (n=12) |
Patients with Hypertension (n=53) |
P Value | |
|---|---|---|---|---|
| Mean Age | 79 | 80 | 79 | p=0.933 |
| Sex (Female) | 78% | 70% | 80% | p=0.271 |
| Diabetes mellitus | 22% | 17% | 23% | p=0.649 |
| Hyperlipidermia | 51% | 25% | 57% | p=0.048 |
| Coronary artery disease | 11% | 0% | 13% | p=0.183 |
| Atrial fibrillation | 35% | 25% | 38% | p=0.405 |
| Hypertension | 82% | 0% | 100% | |
| IV tPA | 26%α | 25% | 26%β | p=0.942 |
| Median Pretreatment NIHSS | 8 | 8.5 | 7.5 | p=0.357 |
| Fazekas Score, Periventricular White Matter – 2 | 24%* | 42% | 20%# | p=0.027 |
| Fazekas Score, Periventricular White Matter – 3 | 76%* | 58% | 80%# | |
| Fazekas Score, Deep White Matter – 2 | 17%* | 8% | 20%# | p=0.355 |
| Fazekas Score, Deep White Matter – 3 | 83%* | 92% | 80%# | |
| Mean Permeability Derangement | 1.9% | 2.3% | 1.9% | p=0.04 |
α
n=62,
β
n=50,
*
n=63,
#
n=51.